Morgan Stanley, NVIDIA

Morgan Stanley Bangs the Drum on Nvidia Stock
Nvidia (NASDAQ:NVDA) stock might be a multi-year winner with its leadership in AI chips propelling it right to the very top of the stock market
Nvidia rises after Morgan Stanley maintains Top Pick tag following DeepSeek impact
Morgan Stanley reiterated Nvidia (NASDAQ:NVDA) as its Top Pick, noting that DeepSeek (DEEPSEEK) selloff is a buying opportunity. Shares of Nvidia rose about 2% on Thursday. Analysts led by Joseph Moore said that sentiment has worsened around potential longer term risks,
Morgan Stanley maintains Workday stock at Overweight, target $330
Morgan Stanley (NYSE:MS) reiterated its Overweight rating and $330.00 price target on Workday (NASDAQ:WDAY), a prominent player in the software industry with a market capitalization of $72.85 billion,
‘DeepSeek Is a Big Threat,’ Says Top Analyst About Nvidia Stock
Nvidia (NASDAQ:NVDA) shares had a nice rally today, surging nearly 5%. Yet, the stock hasn’t fully recovered from the recent bombshell dropped
Nvidia Stock Climbs As Morgan Stanley Reaffirms Top Pick Status Despite DeepSeek Drop: Retail Remains Bullish
Shares of Nvidia Corp. (NVDA) gained nearly 3% in mid-day trade on Thursday after analysts at Morgan Stanley shrugged off the DeepSeek sell-off. Since DeepSeek’s launch on Jan. 24, Nvidia’s stock has lost over 10% of its value.
Morgan Stanley cuts Regeneron stock price target to $1,150
Pharmaceuticals stock, reducing the price target from $1,185.00 to $1,150.00. Despite the decrease, the firm maintained its Overweight rating on the NASDAQ-listed company. According to InvestingPro data,
Nasdaq9d
Top Analysts’ Picks for 2025: 3 of Morgan Stanley's Favorites
Below, I'll detail three stocks that are among the “Top Picks” of Morgan Stanley analysts. All return and implied upside figures use prices as of the Jan. 27 close. First up is Seagate ...
NVIDIA Corporation (NVDA) – Buy the Dip? Morgan Stanley Stays Bullish
We recently published a list of 10 Must-Watch AI Stocks Dominating Headlines. In this article we are going to look at where ...
Morgan Stanley cuts Varonis stock price target to $54
Morgan Stanley (NYSE:MS) adjusted its outlook on Varonis Systems (NASDAQ:VRNS), reducing the price target to $54 from the previous $60. Despite this change, the firm maintained its Overweight rating ...
Nurix Therapeutics (NASDAQ:NRIX) Stock Price Expected to Rise, Morgan Stanley Analyst Says
Nurix Therapeutics (NASDAQ:NRIX – Get Free Report) had its price objective lifted by analysts at Morgan Stanley from $16.00 ...